Acquired Resistance to EGFR-TKI in the Uncommon EGFR Mutation, G719S

被引：0
|
作者：
Osoegawa, A. [1 ]
Hashimoto, T. [1 ]
Takumi, Y. [1 ]
Kobayashi, R. [1 ]
Miyawaki, M. [1 ]
Takeuchi, H. [1 ]
Okamoto, T. [1 ]
Sugio, K. [1 ]
机构：
[1] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Yufu, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Acquired resistance; EGFR-TKI; PTEN;
D O I：
10.1016/j.jtho.2017.09.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02-039
引用
下载
收藏
页码：S2251 / S2251
页数：1
相关论文
共 50 条
  • [31] Efficacy of EGFR-TKI for Lung Adenosquamous Cell Carcinoma Harboring EGFR Mutation
    Liu, Y.
    Xia, X.
    Du, W.
    Zhang, Y.
    Xu, J.
    Gong, Y.
    Zhu, J.
    Ding, Z.
    Peng, F.
    Huang, M.
    Xu, Y.
    Wan, J.
    Ren, L.
    Lu, Y.
    Han, B.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2380 - S2380
  • [32] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Effects of an Alkaline Diet on EGFR-TKI Therapy in EGFR Mutation-positive NSCLC
    Hamaguchi, Reo
    Okamoto, Toshihiro
    Sato, Masaaki
    Hasegawa, Michiko
    Wada, Hiromi
    ANTICANCER RESEARCH, 2017, 37 (09) : 5141 - 5145
  • [34] Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
    Da Hyun Kang
    Sung Soo Jung
    Min-Kyung Yeo
    Da Hye Lee
    Geon Yoo
    Sang Yeon Cho
    In-Jae Oh
    Ju-Ock Kim
    Hee Sun Park
    Chaeuk Chung
    Jeong Eun Lee
    BMC Cancer, 20
  • [35] The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
    Chung, Fu-Tsai
    Ho, Ming-Yun
    Fang, Yueh-Fu
    Hshieh, Meng-Heng
    Wang, Tsai-Yu
    Kuo, Chih-Hsi
    Chen, Hao-Cheng
    Wang, Chun-Hwa
    Lin, Shu-Min
    Yu, Chih-Teng
    Lin, Horng-Chyuan
    Kuo, Han-Pin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
    Azuma, Koichi
    Takahama, Takayuki
    Sakai, Kazuko
    Takeda, Masayuki
    Hida, Toyoaki
    Hirabayashi, Masataka
    Oguri, Tetsuya
    Tanaka, Hiroshi
    Ebi, Noriyuki
    Sawa, Toshiyuki
    Bessho, Akihiro
    Tachihara, Motoko
    Akamatsu, Hiroaki
    Bandoh, Shuji
    Himeji, Daisuke
    Ohira, Tatsuo
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390
  • [37] Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
    Kang, Da Hyun
    Jung, Sung Soo
    Yeo, Min-Kyung
    Lee, Da Hye
    Yoo, Geon
    Cho, Sang Yeon
    Oh, In-Jae
    Kim, Ju-Ock
    Park, Hee Sun
    Chung, Chaeuk
    Lee, Jeong Eun
    BMC CANCER, 2020, 20 (01)
  • [38] Study on the Molecular Mechanism of RBM5 Reverse the Acquired Resistance to EGFR-TKI
    Zhang, J.
    Xu, Y.
    Su, Z.
    Li, J.
    Wang, Q.
    Zhang, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [39] Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC
    Li, Shuai
    Zhou, Fangyu
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2014, 84 (02) : 203 - 205
  • [40] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
    Lin, Yuxin
    Wang, Xian
    Jin, Hongchuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (05): : 411 - 435
12345